Benitec Biopharma Limited - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Benitec Biopharma Limited - Product Pipeline Review - 2014" provides data on the Benitec Biopharma Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Benitec Biopharma Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Benitec Biopharma Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Benitec Biopharma Limited - Brief Benitec Biopharma Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Benitec Biopharma Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Benitec Biopharma Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Benitec Biopharma Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Benitec Biopharma Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Benitec Biopharma Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Benitec Biopharma Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Benitec Biopharma Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Benitec Biopharma Limited and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Benitec Biopharma Limited Snapshot 4
Benitec Biopharma Limited Overview 4
Key Information 4
Key Facts 4
Benitec Biopharma Limited - Research and Development Overview 5
Key Therapeutic Areas 5
Benitec Biopharma Limited - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Out-Licensed Products 9
Out-Licensed Products/Combination Treatment Modalities 10
Benitec Biopharma Limited - Pipeline Products Glance 11
Benitec Biopharma Limited - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Benitec Biopharma Limited - Drug Profiles 13
ddRNAi Program For Cancer-Associated Pain 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ddRNAi Program For Hepatitis B 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Drug-Resistant Lung Cancer Program 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ddRNAi Program For Oculopharyngeal Muscular Dystrophy 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Benitec Biopharma Limited - Pipeline Analysis 20
Benitec Biopharma Limited - Pipeline Products by Therapeutic Class 20
Benitec Biopharma Limited - Pipeline Products by Target 21
Benitec Biopharma Limited - Pipeline Products by Route of Administration 22
Benitec Biopharma Limited - Pipeline Products by Molecule Type 23
Benitec Biopharma Limited - Pipeline Products by Mechanism of Action 24
Benitec Biopharma Limited - Recent Pipeline Updates 25
Benitec Biopharma Limited - Company Statement 27
Benitec Biopharma Limited - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables
Benitec Biopharma Limited, Key Information 4
Benitec Biopharma Limited, Key Facts 4
Benitec Biopharma Limited - Pipeline by Indication, 2014 6
Benitec Biopharma Limited - Pipeline by Stage of Development, 2014 7
Benitec Biopharma Limited - Monotherapy Products in Pipeline, 2014 8
Benitec Biopharma Limited - Out-Licensed Products in Pipeline, 2014 9
Benitec Biopharma Limited - Out-Licensed Products/ Combination Treatment Modalities, 2014 10
Benitec Biopharma Limited - Preclinical, 2014 11
Benitec Biopharma Limited - Discovery, 2014 12
Benitec Biopharma Limited - Pipeline by Therapeutic Class, 2014 20
Benitec Biopharma Limited - Pipeline by Target, 2014 21
Benitec Biopharma Limited - Pipeline by Route of Administration, 2014 22
Benitec Biopharma Limited - Pipeline by Molecule Type, 2014 23
Benitec Biopharma Limited - Pipeline Products by Mechanism of Action, 2014 24
Benitec Biopharma Limited - Recent Pipeline Updates, 2014 25
Benitec Biopharma Limited, Other Locations 29
Benitec Biopharma Limited, Subsidiaries 29